Putting Her Faith in Research & Her Doctor
All things considered, things are looking up for Margaret Oplinger. A marble-sized tumor is all that’s left of her Stage 4 melanoma; and her ongoing treatment, every-other week with nivolumab (Opdivo®), will hopefully enable her immune system to attack – and eliminate – this last remnant.
Basic Research: Understanding what Triggers Melanoma and its Spread to Identify New Treatment Targets
9 July 2020 In Science
Tremendous progress has been made in understanding the basic biology needed to trigger melanoma and fuel its growth and progression. Researchers continue to probe deeper, finding new molecular culprits that could lead to novel and more effective melanoma treatment strategies. Some of these new potential drug targets were revealed at MRA’s 2020 Scientific Retreat.
Melanoma Research Updates from 2020 AACR and ASCO Conferences
MRA Chief Science Officer Marc Hurlbert shares exciting melanoma research highlights from ASCO and AACR - the two largest global cancer research conferences that take place annually.
Painting a Portrait of the Melanoma Clinical Trial Participant
MRA Chief Science Officer Marc Hurlbert, MRA Director of Communications Cody Barnett, and Antidote's Head of Partnerships Lindsey Wahlstrom-Edwards discuss what matters most to melanoma patients when it comes to participating in clinical trials.
Maintaining Momentum in Melanoma Research
The last decade has been one of substantial progress and hope for many melanoma patients, researchers, and clinicians. With 12 new therapeutic approaches now approved to treat melanoma, many advanced-stage patients are seeing their tumors shrink or disappear, and are experiencing renewed hope for a brighter future.
From Dermatology to Treatment: Second Opinions, Clinical Trials & becoming Your Own Best Advocate
Through his journey with melanoma, Patrick has learned the importance of always being his own best advocate, getting second opinions, and considering clinical trials.
Facing Melanoma Together
Measuring the progress of melanoma research through numbers isn’t hard. What’s harder to quantify – or to even put into words – is the individual impact that this research makes in the lives of patients and their loved ones. It's this human impact that Facing Melanoma Together, a series of black and white photographs, helps bring to the forefront.
From Anger to Hope – One Uveal Melanoma Patient’s Journey
Unlike many of the stories featured by CureMelanoma.org, Melody Burchett’s journey with melanoma didn’t start at her dermatologist’s office. Instead, Melody's journey with melanoma began with a pair of broken glasses that needed replacing, ASAP.
Lighting up Melanoma (One Cell at a Time)
Meet Aditi Sahu, a post-doctoral fellow at Memorial Sloan Kettering Cancer Center, and MRA Dermatology Research Fellow. Learn about her work and MRA's Dermatology Fellowship Award Program.